- Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle The Wall Street Journal
- Pfizer Wins Obesity Drug Prize, With Trump Administration Assist Yahoo Finance
- Breakingviews – Pfizer’s obesity win is new formula for pharma M&A Reuters
- Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer Bloomberg.com
- Novo Nordisk walked away from a $10 billion biotech deal — and investors aren’t sure if that’s smart or scary CNBC
Source link
